Senior insider sale
See Remarks at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$5.09M
57.73K shares
What this filing means
KING-JONES HEIDY plans to sell 57.73K shares of SPYRE THERAPEUTICS, INC. valued at approximately $5.09M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2026ACC: 0001950047-26-009971
Officer· See Remarks
Since Sep 2023
57.73K
Shares to sell
$5.09M
Approx. market value
29.34K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
10/1/2026
29.34KTotal acquired29.34K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2026 | Exercise of Stock Options Cash | 29.34K | — |
| Total | 29.34K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
400.00
Market value
$36.0K
9/2/2026
—Completed
Units to sell
28K
Market value
$2.44M
9/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
29.34K
Market value
$2.61M
10/1/2026
Total
Units
57.73K
Value
$5.09M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2026 | 400.00 | $36.0K | — | Completed |
9/1/2026 | 28K | $2.44M | — | Completed |
| Planned — Approximate Date | ||||
10/1/2026 | 29.34K | $2.61M | NASDAQ | Planned |
| Total | 57.73K | $5.09M | ||